title: Magnesium and parathyroid hormone changes to magnesium-free dialysate in continuous ambulatory peritoneal dialysis patients.
abstract: OBJECTIVE
  For the normalization of serum magnesium (Mg) concentration, dialysate Mg concentration tends to be reduced in continuous ambulatory peritoneal dialysis (CAPD) patients. The aim of this study was to evaluate the influence of Mg on parathyroid hormone (PTH).
  
  
  METHODS
  Prospective study of the utilization of Mg-free dialysate for 8 weeks.
  
  
  METHODS
  Dialysis service, Itabashi Hospital, Nihon University School of Medicine.
  
  
  METHODS
  Five stable CAPD patients (1 male; 4 female; age 49.7 +/- 1.3 years; duration of CAPD 27 +/- 9 months).
  
  
  METHODS
  Serum Mg, serum high sensitive PTH, and Mg content in mononuclear cells were measured at 4-week intervals.
  
  
  RESULTS
  In comparison to baseline, serum Mg concentration was significantly reduced at week 4 (p < 0.01) and week 8 (p < 0.01), and serum PTH was significantly increased at week 4 (p < 0.05) and at week 8 (p < 0.05). However, the PTH level at week 8 was lower than that at week 4. Furthermore, the Mg content in mononuclear cells was significantly decreased at week 4 (p < 0.01) and at week 8 (p < 0.01). Serum-ionized calcium and phosphate concentrations did not change.
  
  
  CONCLUSIONS
  The removal of Mg by Mg-free dialysate leads to Mg depletion in CAPD patients. In addition, Mg depletion stimulates PTH synthesis or secretion at 4 weeks, but at 8 weeks PTH synthesis or secretion is also influenced by other factors.
authors.affiliation: Nishi-Kofu National Hospital, Yamanashi, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Takahashi
authors.forename: K
authors.initials: K
authors.lastname: Okada
authors.forename: M
authors.initials: M
authors.lastname: Yanai
mesh_terms: D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D003404:Creatinine / Q000097:blood; D015314:Dialysis Solutions / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000737:chemistry; D008214:Lymphocytes / Q000737:chemistry; D008274:Magnesium / Q000008:administration & dosage* / Q000097:blood* / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D010710:Phosphates / Q000097:blood; D011446:Prospective Studies
chemical_list: D015314:Dialysis Solutions; D010281:Parathyroid Hormone; D010710:Phosphates; D003404:Creatinine; D008274:Magnesium; D002118:Calcium